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Available online 13 August 2014Abstract Methamphetamine (METH) is a highly addictive psychostimulant drug of abuse that negatively interferes with
neurogenesis. In fact, we have previously shown that METH triggers stem/progenitor cell death and decreases neuronal
differentiation in the dentate gyrus (DG). Still, little is known regarding its effect on DG stem cell properties. Herein, we investigate
the impact of METH on mice DG stem/progenitor cell self-renewal functions. METH (10 nM) decreased DG stem cell self-renewal,
while 1 nM delayed cell cycle in the G0/G1-to-S phase transition and increased the number of quiescent cells (G0 phase), which
correlated with a decrease in cyclin E, pEGFR and pERK1/2 protein levels. Importantly, both drug concentrations (1 or 10 nM) did not
induce cell death. In accordance with the impairment of self-renewal capacity, METH (10 nM) decreased Sox2+/Sox2+ while
increased Sox2−/Sox2− pairs of daughter cells. This effect relied on N-methyl-D-aspartate (NMDA) signaling, which was prevented by
theNMDA receptor antagonist, MK-801 (10 μM). Moreover, METH (10 nM) increased doublecortin (DCX) protein levels consistent with
neuronal differentiation. In conclusion, METH alters DG stem cell properties by delaying cell cycle and decreasing self-renewalAbbreviations: bFGF2, basic fibroblast growth factor 2; BrdU, 5-bromo-2′-deoxyuridine; Cdk, cyclin-dependent kinase; DCX, doublecortin; DG,
dentate gyrus; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; ERK, extracellular-signal-regulated kinases 1/2; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; GFAP, glial fibrillary acidic protein; MAPK, mitogen-activated protein kinase; MDMA,
3,4-methylenedioxymethamphetamine; MEK1, MAPK/ERK kinase 1; METH, methamphetamine; MK-801, (5R,10S)-(−)-5-methyl-10,11-dihydro-
5H-dibenzo[a,d]cylcohepten-5,10-imine maleate; NMDA, N-methyl-D-aspartate; pEGFR, phospho-epidermal growth factor receptor; pERK1/2,
phospho-extracellular-signal-regulated kinases 1/2; SGZ, subgranular zone; Sox2, SRY (sex determining region Y)-box 2; SVZ, subventricular zone;
TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end labeling.
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Methamphetamine (METH) is a highly addictive drug whose
consumption has been increasing worldwide and turned to
be a public health problem (Silva et al., 2010). Several
studies have extensively described the negative effects of
METH in the Central Nervous System (Gonçalves et al.,
accepted for publication; Krasnova and Cadet, 2009), conclud-
ing that METH abusers exhibit smaller hippocampal volume,
which was positively correlated with poorer memory perfor-
mance (Thompson et al., 2004). Accordingly, animal studies
have clearly demonstrated hippocampal neuronal dysfunction
(Gonçalves et al., 2010), as well as cognitive deficits induced
by this psychostimulant (Simões et al., 2007). Nevertheless,
the mechanisms of METH-induced memory deficits are still
poorly understood, but pieces of evidence show that
neurogenesis is tightly related to memory. In fact, reduc-
tion in the number of immature neurons induces deficits
in long-term retention of spatial cognitive functions (Deng
et al., 2009), and ablation of hippocampal neurogenesis
impairs memory performance related to pattern separation
functions (Clelland et al., 2009).
The information available regarding the effect of METH on
neurogenesis describes that, in the dentate gyrus (DG), cell
proliferation is decreased in gerbils (postnatal day 30) admin-
istered once with the drug at postnatal day 14–20 (50 mg/kg)
(Hildebrandt et al., 1999). On the other hand, a lower dose of
METH (25 mg/kg) transiently decreased cell proliferation in the
same region (Teuchert-Noodt et al., 2000). Furthermore, a
chronic METH administration (1 mg/kg/day for 14 days) had no
effect on the number of proliferating cells in mice DG (Maeda
et al., 2007). Interestingly, Wistar rats self-administered with
METH (0.05 mg/kg/infusion, 1 h intermittent access, 2× aweek
during 28 days) displayed an increase in DG cell proliferation as
well as in neuronal differentiation, whereas both short (1 h/day)
and long (6 h/day) access decreased proliferation and differen-
tiation followed by a reduced number of DG granule cell neurons
(Mandyam et al., 2008). Furthermore, self-administration of
METH (1 h/day accessMETH for 13 days) increased the number of
radial glia-like cells (type 1 cells), but decreased the proportion
of preneuronal neuroblasts (type 2a cells) (Yuan et al., 2011)
showing that at different maturation stages cells respond
differently to an external stimuli (Tashiro et al., 2007). Also,
daily access to METH (6 h/day for 4 or 13 days) decreased the
number of proliferating cells in the DG without changing,
however, the length of S-phase of the cell cycle (Yuan et al.,
2011). In vitro studies also point that METH reduced prolifera-
tion of rat hippocampal neural progenitor cells (Tian et al.,
2009; Venkatesan et al., 2011). Additionally, our group recently
verified that a nontoxic concentration of METH (1 nM for 7 days)
decreased the number of mature neurons in DG-derived
neurosphere cultures (Baptista et al., 2012). Concerning the
subventricular zone (SVZ), we have also shown that METHdecreases cell proliferation, neuronal differentiation and
maturation of stem/progenitor cells (Bento et al., 2011).
Overall, it seems clear that METH interferes with hippo-
campal neurogenesis, but many questions remain unanswered.
In fact, the direct effect of this drug on stem cell self-renewal
capacities has never been addressed before. Herein, we show
that METH delays cell cycle progression from G0/G1-to-S
phase. This effect could be due to the down-regulation of
cyclin E, a cyclin involved in the progression through the G1
phase and initiation of DNA replication in the S phase, and to
the decrease of epidermal growth factor receptor (EGFR) and
extracellular-signal-regulated kinases 1/2 (ERK1/2) phosphor-
ylation, mediators in the MAPK signaling pathway involved in
cell proliferation progression. Also, METH decreases DG stem
cell self-renewal capacities, which seems to involve NMDA
receptors. In conclusion, the present work reveals a negative
impact of METH on DG stem cell capacities that can contribute
to memory deficits upon METH consumption.
Material and methods
Dentate gyrus neurosphere cultures
Post-natal 1–3-day-old C57BL/6J mice were sacrificed by
decapitation and the brains were placed in sterile saline
solution. Afterwards, the meninges were removed and DG
fragments were dissected from 450 μm-thick brain coronal
sections, digested in 0.025% trypsin and 0.265 mM EDTA
(both from Life Technologies, Carlsbad, CA, USA), and single
cells were obtained by gentle trituration. Then, cells were
diluted in serum-free culture medium (SFM) composed of
Dulbecco's modified Eagle's medium/Ham's (DMEM) F-12 medi-
um GlutaMAX-I supplemented with 100 U/ml penicillin,
100 μg/ml streptomycin, 1% B27 supplement, 5 ng/ml epider-
mal growth factor (EGF) and 2.5 ng/ml basic fibroblast growth
factor (bFGF-2) (all from Life Technologies). Afterwards, cells
were plated in uncoated Petri dishes and neurospheres were
allowed to develop for 6 days in a 95% air–5% CO2 humidified
atmosphere at 37 °C. At 6 days, the neurosphere mean
diameter was 90.22 ± 2.24 μm (measurements performed
on 2 independent cultures).
Experimental procedures were performed according to
the guidelines of the European Communities Council Direc-
tives (2010/63/EU) and the Portuguese law for the care and
use of experimental animals (DL no. 129/92). All efforts
were made to minimize animal suffering and to reduce the
number of animals.
Cell death assay
DG neurospheres were exposed to 10 or 100 nM METH
(Department of Chemistry and Biochemistry, Faculty of
Sciences, University of Porto, Portugal) for 24 h (Fig. 1A)
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Kit (Stem Cell Technologies, Grenoble, France). Cells were
adhered to SuperFrost Plus glass slides (Thermo Scientific,
Menzel GmbH & Co. KG, Braunschweig, Germany) by centrifu-
gation (360 ×g, 5 min; Cellspin I, Tharmac GmbH, Waldsolms,
Germany), and fixed in 4% paraformaldehyde (PFA). After-
wards, terminal deoxynucleotidyl transferase dUTP nick-end
labeling (TUNEL) assay was performed to label apoptotic
nuclei, as previously described by us (Baptista et al., 2012).
Briefly, cells were rinsed 3× for 10 min with 0.01 M phosphate-
buffered saline (PBS) and permeabilized in 0.25% Triton X-100
for 30 min at room temperature. Cells were then incubated
with terminal deoxynucleotidyl transferase buffer (0.25 U/μl
terminal transferase, 6 μM biotinylated dUTP, pH 7.5; Roche,
Basel, Switzerland) for 1 h at 37 °C in a humidified chamber.
Afterwards, cells were rinsedwith a termination buffer solution
(300 mM NaCl and 30 mM sodium citrate) for 15 min, followed
by PBS for 5 min and incubated with Fluorescein (1:100;
Vector Laboratories, Burlingame, USA) for 1 h. Additional SRY
(sex determining region Y)-box 2 (Sox2) immunostaining was
performed (as described in the Immunocytochemistry section)
to identify stem cells. Finally, nuclei were counterstained
with 4 μg/ml Hoechst 33342 (Sigma-Aldrich) for 5 min and
mounted in Dako fluorescence mounting medium (Dako,
Glostrup, Denmark). Cell counts were obtained from 6
microscope fields of each coverslip, from 3 independent
cultures performed in triplicate.Figure 1 METH can induce DG stem/progenitor cell death. (A) Sch
cell death. DG neurospheres were exposed to METH (10 or 100 nM)
determined to evaluate apoptotic cell death of stem cells. (B) Re
(green) of a Sox2-positive stem cell (red) from a control condition. S
cells in the presence of 10 or 100 nM METH. Only the highest conc
control + SEM from at least 2 independent cultures where each c
different from control, using Kruskal–Wallis test followed by Dunn'sImmunocytochemistry
DG cell cultures or neurospheres were fixed in 4% PFA for
30 min, permeabilized in 1% Triton X-100 and 3% bovine serum
albumin (BSA; all from Sigma-Aldrich, St Louis, MO, USA) in PBS,
followed by overnight incubation at 4 °C with the following
antibodies: goat polyclonal anti-Sox2 (1:200; Santa Cruz
Biotechnology, Heidelberg, Germany), goat anti-doublecortin
(DCX, 1:500; Santa Cruz Biotechnology) and rabbit polyclonal
anti-glial fibrillary acidic protein (GFAP, 1:500; Sigma-Aldrich).
Then, cells were rinsed with PBS and incubated for 1 h with the
appropriate secondary antibodies: donkey anti-goat Alexa
Fluor 594 or donkey anti-rabbit Alexa Fluor 488 (both
1:200; Life Technologies). Afterwards, nuclei were stained
with 4 μg/ml Hoechst 33342 (Sigma-Aldrich) and slides were
mounted in Dako. Fluorescence images for cell counts were
recorded using a fluorescence microscopy (Leica DMIRE200,
Wetzlar, Germany).Cell cycle analysis
Six-day-old DG primary neurospheres were exposed to 1 nM
METH for 24 h or 72 h (Fig. 2A), dissociated and fixed in 70%
ethanol for 20 min at 4 °C. Then, cells were centrifuged at
550 ×g for 5 min and resuspended in a solution containing 2%
Fetal Bovine Serum (FBS; Life Technologies) in PBS. Afterwards,ematic representation of the experimental design to assess DG
for 24 h and the number of TUNEL- and Sox2-positive cells was
presentative fluorescence images of a TUNEL-positive nucleus
cale bar: 10 μm. (C) Quantification of TUNEL- and Sox2-positive
entration was toxic to stem cells. Data are expressed as % of
ondition was performed in duplicate. **P b 0.01, significantly
multiple comparison post-hoc test.
332 S. Baptista et al.106 cells/ml was incubated with 10 μM Vybrant® Dye Cycle
Orange (Life Technologies), which is a DNA-selective and
membrane permeant probe that binds stoichiometrically to
DNA and becomes fluorescent upon binding, in the presence
of 0.1% Triton X-100 for 45 min at 37 °C. Afterwards, cells
in suspension were centrifuged at 550 ×g for 5 min and
resuspended in 2% FBS in PBS. Approximately 30,000 events
were analyzed on a FACSCalibur flow cytometer (Becton
Dickinson, San Jose, CA, USA) and cell cycle was analyzed
using the ModFit software.
Cell quiescence was assessed in DG neurospheres treated
with 1 nM METH for 24 h (Fig. 2A). Neurospheres were
dissociated to single cells (NeuroCult®) and incubated for
15 min at 37 °Cwith 1 μg/ml Hoechst 33342 (Life Technologies)Figure 2 METH delays DG neurosphere cell cycle in the transit
quiescence. (A) Schematic representation of the experimental proto
in different phases of the cell cycle after (B) 24 h or (C) 72 h of METH
G1 phase while decreasing the S phase. (C) In contrast, METH does n
expressed as % of cells + SEM from at least 2 independent culture
significantly different from control using Mann Whitney post-hoc t
quiescent phase (G0) as shown by the representative dot plots (reprand 1 μg/ml pyronin-Y (Sigma-Aldrich), a fluorescent probe
that binds to RNA, in culture medium supplemented with
0.1% Triton. Then, cells were centrifuged for 5 min at
550 ×g, resuspended in culturemedium and analyzed on a FACS
Aria III (Becton Dickinson). In detail, pyronin-Y was excited at
488 nm and red fluorescence was collected at 545/35 nm, and
Hoechst 33342 was excited at 355 nm (UV) and blue fluores-
cence was recorded at 450/50 nm. A total of 10,000 cells were
analyzed per sample at a velocity of 400 events/s. Proper
controls consisting of cells incubated with either Hoechst 33342
or Pyronin-Y were performed to calibrate the cytometer. Also,
to exclude dead cells, DG cells were incubated with 2 μg/ml
propidium iodide (Sigma-Aldrich). Data were analyzed using the
FlowJo software.ion from G0/G1 to S phase and induces stem/progenitor cell
col for cytometry analysis. (B, C) Quantification of cells present
exposure. (B) METH increases the population of cells in the G0/
ot induce any alterations in cell cycle at 72 h exposure. Data are
s and each condition was performed in duplicate. **P b 0.01,
est. (D) METH (1 nM for 24 h) increases the number of cells in
esentative experiment of 3 independent cultures).
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To evaluate cyclin A, D1 and E protein levels, 6-day-old
neurospheres were exposed to 1 nM METH or to 10 nM METH
for cyclin E protein level determination during 24 h (Fig. 3A).
Moreover, phospho-epidermal growth factor receptor (pEGFR),
epidermal growth factor receptor (EGFR), phospho-fibroblast
growth factor receptor 1 (pFGFR1), phospho-extracellular-
signal-regulated kinases 1/2 (pERK1/2) and extracellular-
signal-regulated kinases 1/2 (ERK1/2) protein levels were
analyzed in DG neurospheres exposed to 1 or 10 nM METH for
6 or 24 h (Fig. 4A). Regarding DCX and GFAP protein levels,
DG cells were exposed to 1 or 10 nM METH for 6 days (Fig. 7A)Figure 3 METH down-regulates cyclin E protein levels in DG neurosph
western blot studies. METH (1 nM) does not induce alterations in (B) c
(C) down-regulates cyclin E (53 kDa) expression, which is also observed a
(F) p21 (21 kDa) and (G) p27 (27 kDa) expressions, the main inhibitors o
Above the bars, representative western blot images of the different prot
GAPDH (36 kDa). Data are expressed as % of control + SEM from at le
control using Mann Whitney post-hoc test.and the resulting neurospheres were harvested. Then, DG
neurospheres were homogenized in RIPA buffer containing
150 mM NaCl, 5 mM EGTA, 50 mM Tris, 1% (v/v) Triton X-100,
0.1% SDS and 0.5% sodium deoxycholate, supplemented with a
protease inhibitor cocktail tablet (Roche, Amadora, Portugal)
in the ratio of 1 tablet/10 ml RIPA buffer. Afterwards, cells
were centrifuged at 17,000 ×g for 15 min and protein concen-
tration was determined using the bicinchoninic acid (BCA)
Protein Assay (Thermo Fisher Scientific, Northumberland,
UK). Then, 10 μg or 30 μg of protein samples was separated
by electrophoresis in a 8% or 12% SDS-PAGE, respectively,
transferred to a polyvinylidene difluoride (PVDF) mem-
brane (Millipore, Algés, Portugal) and blocked in a solutioneres. (A) Schematic representation of the experimental design for
yclin D1 (37 kDa) or (E) cyclin A (60 kDa) protein expression, but
t (D) 10 nMMETH. Additionally, METH (1 nM) does not interferewith
f the complexes cyclin D1/Cdk4/6 and cyclin E/Cdk2, respectively.
eins are shown, including the housekeeping gene β-actin (42 kDa) or
ast 4 independent cultures. *P b 0.05, significantly different from
Figure 4 METH down-regulates the phosphorylation form of EGFR and ERK1/2. (A) Schematic representation of the experimental design
for western blot studies. Exposure to METH (1 nM) for 6 h does not induce any effect in (B) pFGFR1 (130 kDa), but (C) down-regulates the
phosphorylation levels of EGFR (175 kDa). In addition, (D) 1 nMor (E) 10 nMMETHdecreases the phosphorylation formof ERK1/2 (42/44 kDa)
after 6 h of drug exposure, but no alterationswere observed after 24 h. Data are expressed as % of control + SEM from at least 4 independent
cultures. *P b 0.05, significantly different from control using Mann Whitney or Kruskal–Wallis test followed by Dunn's multiple comparison
post-hoc tests. §§P b 0.01, significantly different from METH 6 h-exposure using Kruskal–Wallis test followed by Dunn's multiple comparison
post-hoc test.
334 S. Baptista et al.of 5% non-fat dried milk or 4% BSA in PBS-0.5% Tween (PBS-T;
Sigma-Aldrich) for 1 h. Membranes were probed overnight at
4 °C with mouse monoclonal anti-cyclin A (1:200; Abcam,
Cambridge, UK), mouse monoclonal anti-cyclin D1 (1:100),
mouse monoclonal anti-cyclin E (1:100), rabbit polyclonal
anti-p21 (1:200), mouse monoclonal anti-p27 (1:200) (all
from Santa Cruz Biotechnology), mouse monoclonal anti-
phosphotyrosine (p-tyr clone 4G10, 1:200; Millipore), rabbit
polyclonal anti-EGFR (1:200; Abcam), rabbit monoclonal
anti-pFGFR1 (1:200; Abcam), rabbit monoclonal anti-pERK1/
2 (Thr202/Tyr204; 1:200; Cell Signaling Technology, Beverly,MA, USA), rabbit monoclonal anti-ERK1/2 (1:200; Cell Signaling
Technology), rabbit polyclonal anti-GFAP (1:1000;
Sigma-Aldrich), goat polyclonal anti-DCX (1:200; Santa Cruz
Biotechnology), mouse monoclonal anti-β-actin (1:10,000;
Sigma-Aldrich) and rabbit polyclonal anti-GAPDH (1:500;
Sigma-Aldrich). Then, membranes were washed and incubated
for 45 min with alkaline phosphatase-conjugated secondary
antibodies as follows: anti-rabbit IgG (1:20,000; GE Healthcare
Europe GmbH, Freiburg, Germany), anti-mouse (1:10,000, GE
Healthcare Europe GmbH) and anti-goat IgG (1:10,000, Zymax,
California, USA). Densitometric analysis was performed using
335Methamphetamine impairs dentate gyrus stem cell propertiesthe ECF reagent (GE Healthcare Europe GmbH), visualized
on the Typhoon 9000 system (GE Healthcare Europe GmbH),
and band intensities were quantified using the ImageQuant 5.0
software.
Neurosphere self-renewal assay
Self-renewal capacity of DG stem/progenitor cells was assessed
using the neurosphere assay. In detail, DG cells were seeded
at clonal density of 10 cells/μl (Coles-Takabe et al., 2008;
Pastrana et al., 2011) into uncoated 24-well plates and
incubated with 1 or 10 nM METH for 6 days and the total
number of primary neurospheres in each well was determined
(Fig. 5A). Afterwards, primary neurospheres were dissociated
(NeuroCult® chemical dissociation kit, Stem Cell Technolo-
gies) and cells were reseeded as aforementioned without
treatments for 6 additional days (Fig. 4A). The total number
of resulting secondary neurospheres was determined in each
well. Results are expressed as percentage of the control
(untreated) in both primary and secondary neurospheres from
at least 3 independent cultures and performed in triplicate (3
wells per condition within the 24-well plate).
Cell-fate studies: cell pair assay
Uncommitted stem cells can divide symmetrically into two
stem cells (Sox2+/Sox2+) or into two progenitor cells (Sox2−/
Sox2−), or asymmetrically into one uncommitted cell and one
committed progenitor cell (Sox2+/Sox2−). Taking advantageFigure 5 METH decreases DG neurosphere self-renewal. (A) Schem
impact of METH on self-renewal capacity of DG stem/progenitor cells.
but does not induce any effect on the number of secondary neurospher
of primary and secondary neurospheres. Data are expressed as % of co
performed in triplicate. *P b 0.05; **P b 0.01, significantly different fof these properties, we analyzed if METH interferes with
cell-fate division. For that, cell pair assay was performed as
previously described (Bernardino et al., 2012; Santos et al.,
2012; Xapelli et al., 2013) with some modifications. Hence,
stem cells were directly isolated frommice DG and 10,000 cells
(8840 cells/cm2) were plated onto poly-D-lysine-coated (Sigma-
Aldrich) glass coverslips. After seeding, cells were pre-
incubated with 10 μM (5R,10S)-(−)-5-methyl-10,11-dihydro-
5H-dibenzo[a,d]cylcohepten-5,10-imine maleate (MK-801;
Tocris) for 15 min and then co-exposed with 1 or 10 nM
METH for 24 h (Fig. 6A). Then, immunocytochemistry to Sox2
was performed (Immunocytochemistry section). A total of 40
pairs of daughter cells that resulted from the division of one
stem cell were characterized according to its symmetric cell
division towards self-renewal (Sox2+/Sox2+) and differentia-
tion (Sox2−/Sox2−), or asymmetric cell division (Sox2+/Sox2−).
Results are expressed as percentage of control (untreated)
from at least 2 independent cultures performed in triplicate.Data analysis
Statistical analysis was determined from at least two
independent cultures and by using an analysis of variance
(one-way ANOVA) followed by Dunn's multiple comparison or
MannWhitney post-hoc tests, as indicated in the figure legends.
Data are expressed asmean + standard error of themean (SEM)
from at least 2 independent cultures in which each condition
was performed in duplicate or triplicate, and statistical
significance level was set for P b 0.05.atic representation of the experimental design to evaluate the
(B) METH (1 nM) decreases the number of primary neurospheres,
es. (C) However, 10 nM METH is able to decrease both the number
ntrol + SEM from 3 independent cultures and each condition was
rom control using Mann–Whitney post-hoc test.
Figure 6 METH triggers DG cell-fate division towards differen-
tiation via activation of NMDA receptors. (A) Schematic represen-
tation of the experimental design to evaluate how METH interferes
with cell fate. (B) METH (1 nM) does not induce any alterations in
DG cell-fate division. (C) Nevertheless, a higher concentration of
the drug (10 nM METH) decreases the number of Sox2+/Sox2+ pairs
of daughter cells, which was completely prevented by the NMDA
receptor inhibitor, MK-801 (10 μM), and increases the number of
Sox2−/Sox2− pairs of cells without altering asymmetric cell division
(Sox2+/Sox2−). Data are expressed as % of control + SEM from at
least 2 independent cultures where each condition was performed
in triplicate. **P b 0.01, significantly different from control using
Kruskal–Wallis test followed by Dunn's multiple comparison
test. §P b 0.05; §§§P b 0.001, significantly different from 10 nM
METH using Kruskal–Wallis test followed by Dunn's multiple
comparison test. (D) Representative fluorescence images showing
Sox2+/Sox2+ (symmetric self-renewing cell division), Sox2+/Sox2−
(asymmetric cell division), and Sox2−/Sox2− (symmetric differen-
tiation division) pairs of cells. Scale bar: 5 μm.
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Methamphetamine can induce dentate gyrus stem
cell death
Several studies have previously shown that METH can be toxic
to different brain cells (Deng et al., 2002; Genc et al., 2003;
Mandyam et al., 2007), but the direct effect of this drug on
DG stem cells has never been addressed before. Thus, in the
present study we started by evaluating the toxic effect of
METH on DG stem cells by quantifying the number of positive
cells for TUNEL and Sox2 (Figs. 1B and C). We observed that
10 nM METH did not induce cell death to Sox2-positive cells
(111.00 + 24.51% of control; Fig. 1C). However, 100 nM METH
was toxic to DG neurospheres observed by the significant
increase of Sox2- and TUNEL-positive cells (196.20 + 26.26% of
control; P b 0.01; Fig. 1C).
Methamphetamine delays dentate gyrus cell cycle
Based on our previous results (Fig. 1C) and in order to select
drug concentrations more similar to those frequently present
in the brain of METH users, we decided to use 1 and/or 10 nM
of METH in the following studies. Noteworthy, both concen-
trations did not induce stem cell death. Thus, we analyzed the
effect of METH (1 nM) on cell cycle progression and, after
24 h, there was an increase in the population of cells in the
G0/G1 phase (61.59 + 2.77%, P b 0.01) when compared to the
control (48.91 + 2.12%; Fig. 2B). Furthermore, METH induced
a decrease in the percentage of cells in the S phase (control:
36.86 + 2.81%; METH: 27.72 + 1.69%, P b 0.01; Fig. 2B). Re-
garding the G2/M phases, no differences were observed
between METH and control conditions (control: 15.04 + 0.77%;
METH: 13.42 + 1.08%; Fig. 2B). To further clarify if METH
induces cell cycle inhibition or delay, neurospheres were
exposed to 1 nM METH for 72 h (Fig. 2A). We concluded
that METH no longer interfered with G0/G1 (control: 86.82 +
0.57%; METH: 85.41 + 0.92%), S (control: 9.37 + 0.16%; METH:
10.94 + 0.83%) or G2/M phases (control: 3.81 + 0.72%; METH:
3.64 + 0.42%; Fig. 2C), indicating that METH delays cell cycle
progression rather than inhibiting it.
To disclose whether delay in the cell cycle is due to entry
in quiescence (G0), DG neurospheres were exposed to 1 nM
METH for 24 h (Fig. 2A) and then incubated with Hoechst
33342 and pyronin Y to label DNA and mRNA, respectively.
Quiescent cells possess less mRNA than actively cycling cells
and therefore display low levels of pyronin Y-emitted fluores-
cence. As represented in Fig. 2D, METH increased in about 20%
the cell population that rests in G0 (control: 16.5%; METH:
36.4%).
After demonstrating that METH impairs the progression
of DG stem cells from G0/G1 to S phase of the cell cycle, we
further investigated the possible alterations of cyclins D1, E
and A, since these proteins are involved in the cell cycle
progression. It was possible to conclude that METH (1 nM) did
not induce alterations of cyclin D1 (control: 100.00 + 17.06%;
METH: 94.40 + 10.10% of control; Fig. 3B) or cyclin A protein
levels (control: 100.00 + 12.04%; METH: 104.60 + 13.93% of
control; Fig. 3E). On the other hand, the expression of cyclin E
was down-regulated by this drug (control: 100.00 + 4.36%;
METH: 90.20 + 1.52% of control; P b 0.05; Fig. 3C). A similar
337Methamphetamine impairs dentate gyrus stem cell propertiesdown-regulation of cyclin E was observed with 10 nM METH
(control: 100.00 + 12.74%; 10 nM METH: 49.46 + 8.18% of
control; P b 0.05; Fig. 3D). Afterwards, we assessed the
protein levels of both p21 and p27, themain inhibitors of the
complexes cyclin D1/Cdk4/6 and cyclin E/Cdk2, respectively.
Thus, METH neither altered the protein levels of p21 (control:
100.00 + 13.38%; METH: 102.60 + 7.34% of control; Fig. 3F)
nor of p27 (control: 100.00 + 11.64%; METH: 101.40 + 5.93% of
control; Fig. 3G).
Additionally, since activation of ERK1/2 is highly involved
in cell proliferation through the upstream activation of EGFR
(Gampe et al., 2011) or FGFR1 (Xiao et al., 2007), we
determined the effect of METH on the phosphorylation
levels of FGFR1, EGFR and ERK1/2. Indeed, METH (1 nM)
did not change the protein levels of pFGFR1 (control:
100.00 + 9.44%; METH: 86.02 + 12.00% of control; Fig. 4B)
at 6 h of drug exposure, whereas decreased protein levels
of p-tyr at 175 kDa corresponding to EGFR (control:
100.00 + 9.77%; METH: 48.60 + 13.37% of control; P b 0.05;
Fig. 4C) and pERK1/2 (control: 100.00 +3.95%; METH:
82.02 + 2.11% of control, P b 0.05; Fig. 4D) in DG neurospheres
at 6 h post-METH exposure. However, after 24 h of METH
(1 nM) treatment, pERK1/2 protein levels were similar to
control (101.60 + 5.52% of control; Fig. 4D). The same effect
was observed with 10 nM METH (control: 100.00 + 2.68%; METH
6 h: 77.68 + 5.66% of control, P b 0.05; METH 24 h: 123.70 +
13.78% of control; Fig. 4E).
Methamphetamine decreases dentate gyrus
neurosphere self-renewal
DG stem cells have the ability to self-renew and this capacity
was assessed using the neurosphere assay (Coles-Takabe et al.,
2008; Pastrana et al., 2011). Thus, METH (1 nM) decreased the
number of primary neurospheres (control: 100.00 + 5.29%;
METH: 76.77 + 5.29% of control, P b 0.01; Fig. 5B). However,
no differences in the number of secondary neurospheres were
observed (control: 100.00 + 6.05%; METH: 96.79 + 8.56% of
control; Fig. 5B) indicating that 1 nM METH did not interfere
with self-renewal capacity of DG stem/progenitor cells. In
parallel, a higher concentration of METH (10 nM) also decreased
the number of primary neurospheres (72.37 + 2.06% of control,
P b 0.05; Fig. 5C). Interestingly, the number of secondary
neurospheres was also decreased (control: 100.00 + 4.97%;
METH: 76.47 + 3.57% of control, P b 0.01; Fig. 5C) showing that
METH at 10 nM decreases self-renewal capacity.
Methamphetamine shifts cell fate towards differen-
tiation via activation of NMDA receptors
DG stem cells can self-renew, i.e., one stem cell can divide
and give rise at least to one identical cell to itself and/or
generate progenitors that undergo differentiation (Gage,
2000). Herein, we observed that 1 nM METH had no effect on
DG symmetric cell division towards self-renewal (Sox2+/Sox2+:
87.01 + 6.60% of control; Fig. 6B). Similarly, no effect was
verified on symmetric cell division towards differentiation
(Sox2−/Sox2−: 110.90 + 4.63% of control) or on asymmetric
cell division (Sox2+/Sox2−: 99.07 + 7.00% of control; Fig. 6B).
However, 10 nM METH decreased the number of Sox2+/Sox2+
pairs of cells (53.74 + 4.69% of control; P b 0.01), and theblockade of NMDA receptors withMK-801 completely prevented
the effect induced by METH (99.34 + 10.52% of control,
P b 0.05 compared to METH alone; Fig. 6C). Furthermore,
METH induced an increase of Sox2−/Sox2− pairs of cells and
MK-801 also prevented this effect (METH: 191.10 + 8.20%,
P b 0.01; METH + MK-801: 78.57 + 9.82% of control, P b 0.001
compared to METH alone; Fig. 6C). On the other hand, 10 nM
METH did not affect asymmetric cell division (Sox2+/Sox2−;
Fig. 6C).
Methamphetamine increases doublecortin expression
in DG neurospheres
AsMETH directs cell division towards differentiation,we further
evaluated neuronal and astroglial differentiation in DG cells
treated for 6 days with METH (Fig. 7A). Protein levels of DCX
and GFAP, a marker for immature neurons and astrocytes,
respectively, were determined by western blot. We ob-
served that 1 nM METH did not interfere with both DCX
(105.60 + 7.69% of control; Fig. 7B) and GFAP (94.14 + 14.08%
of control; Fig. 7C) protein levels. However, at a higher
concentration (10 nM) METH was able to up-regulate DCX
expression (133.70 + 6.83% of control; P b 0.05; Figs. 7B and
D), whereas no changes were observed in GFAP protein levels
(93.05 ± 4.29% of control, Figs. 7C and D). Overall, these results
demonstrate that 10 nM METH directs DG stem/progenitor cell
differentiation towards the neuronal fate.
Discussion
The present work addresses the effect of the drug of abuse
METH on DG stem cell properties. Indeed, our results show
that METH at nontoxic concentrations impaired stem cell
properties, specifically by decreasing self-renewal capacity,
delaying cell cycle progression and directing cell fate division
towards differentiation. Firstly, we verified thatMETH (100 nM)
induced cell death of Sox2+ DG stem/progenitor cells from free
floating neurospheres, having no effect at a lower concentra-
tion (10 nM). Interestingly, we have previously shown that
exposure to 10 nM METH for 24 h induced cell death on plated
DG-derived neurosphere cultures (Baptista et al., 2012). Thus,
wemay conclude that neurospheres plated on poly-D-lysine and
in a medium devoid of growth factors initiate differentiation
and are more sensitive to METH toxicity as compared to free
floating Sox2+ neurospheres cultured in the presence of growth
factors. This difference may rely on differential abilities to
repair DNA damages (Fernando et al., 2011), to counteract
oxidative stress (Le Belle et al., 2011) and/or METH-induced
apoptosis mechanisms displayed by stem/progenitor cells
versus committed progenitors.
Herein, we also explored for the first time the impact of
METH on the cell cycle of DG stem cells. It was possible to
observe a delay in the transition from G0/G1 to the S phase, an
increase of cell population in the quiescence state (phase G0),
and a down-regulation of cyclin E protein, which forms a
complex with cyclin-dependent kinase 2 (Cdk2) being involved
in the progression through the G1 phase and initiation of DNA
replication in the S phase (Mazumder et al., 2004). Accordingly,
to confirm thatMETHdelays cell cycle progression, the doubling
time for cell division was assessed and we observed that DG
cells undergo two cell divisions in 24 h (data not shown). On the
Figure 7 METH increases immature neurons in DG
neurospheres. (A) Schematic representation of the experimental
design of DG cells to evaluate the effect of METH on DG
neurospheres growth. (B) METH (10 nM) increases DCX (40 kDa)
protein levels, but without an effect on (C) GFAP (50 kDa)
expression. Data are expressed as % of control + SEM from at least
2 independent cultures. *P b 0.05, significantly different from
control using Kruskal–Wallis test followed by Dunn's multiple
comparison test. (D) Representative fluorescence images of DG
neurospheres showing increased DCX (red) immunoreactivity in
DG cells exposed to 10 nM METH, without inducing significant
alterations in GFAP (green) expression. Nuclei were stained with
Hoechst 33342 (blue). Scale bar: 50 μm.
338 S. Baptista et al.other hand, METH did not induce any alterations in both cyclin
D1 and cyclin A protein levels, which lead us to conclude that
METH specifically impairs G1-to-S transition. In fact, little
information is available regarding the effect of METH in cell
cycle. Nevertheless, Yuan et al. (2011) assumed that hippo-
campal proliferating cells may be arrested in the G1 phase by
METH (self-administration of 0.05 mg/kg/injection, 6 h/daily
for 13 days) since they observed a decreased number not only
of cells in the S phase, but also of cells that enter and exit
the S phase without changing, however, its length. In fact,
other psychostimulants like cocaine (10 or 100 μM, nontoxicconcentrations) also interfere with the transition from G1-to-S
phase in AF5 progenitor cells (a rat mesencephalic cell line),
confirmed by the down-regulation of cyclin A2 (Lee et al.,
2008). The authors further demonstrated that this effect was
triggered by oxidative endoplasmic reticulum stress (Lee et al.,
2008). Additionally, Hu et al. (2006) observed that cocaine
inhibited proliferation in human fetal neural progenitor cells
with simultaneous increase of the cyclin-dependent kinase
inhibitor, p21. Moreover, very recently Blanco-Calvo et al.
(2014) showed that acute administration of cocaine (10 mg/kg)
decreases the number of proliferating cells in the subgranular
zone, which was prevented by the inhibition of cannabinoid
CB1 or CB2 receptors. Cannabinoid receptor blockade was also
able to prevent hippocampal-dependent contextual memories
induced by cocaine (Blanco-Calvo et al., 2014).
On the other hand, with the present study we verified that
METH did not alter protein expression of cyclin inhibitors, p21
and p27, which suggests the involvement of other mechanisms
in METH-induced cyclin E down-regulation. In fact, Heo et al.
(2006) showed that blockade of MAPK pathway with PD-98059
(MEK1 inhibitor) decreased both cyclins D1 and E protein levels.
These authors investigated the involvement of MAPK pathway
activation in cell proliferation by stimulating mouse embryonic
stem cells with epidermal growth factor (EGF), which induced
an increase in the phosphorylate state of ERK1/2 and cyclin
E proteins (Heo et al., 2006). Furthermore, homocysteine, a
sulfur-containing intermediate of methionine metabolism,
decreased phosphorylation of ERK1/2 and cyclin E protein
expression in mice SVZ cells incubated with FGF-2 (Rabaneda
et al., 2008). Based on our results, we may suggest that METH
acts upstream to ERK1/2 by decreasing the phosphorylation
levels of EGFR, which will interfere with the MAPK pathway
through down-regulation of pERK1/2 followed by a decrease
in cyclin E expression, that in turn will affect cell cycle
progression and resulting in the impairment of DG stem cell
self-renewal. In fact, little is known regarding the effect of
METH on EGFR, but it was previously demonstrated that
neonatal EGF administration increased METH-induced loco-
motor responses (Mizuno et al., 2004). Still, it was shown
that EGFR plays an active role in promoting cell prolifera-
tion and neuronal differentiation in the SGZ, as well as in
rescuing neurogenesis in aged rats (Jin et al., 2003). Addition-
ally, in a Parkinson's disease animal model, EGFR expression
is down-regulated in proliferating cells in the SVZ (Höglinger
et al., 2004). Furthermore, it was demonstrated that EGFR
expression and signaling were reduced in the SVZ of agedmice,
which resulted in a decrease of cell proliferation and
neurogenesis (Enwere et al., 2004). Consistent with this
finding, we suggest that METH decreases the expression of
pEGFR, which down-regulates MAPK signaling as verified by a
transient decrease of ERK1/2 phosphorylation, which could
lead to down-regulation of cyclin E and, consequently, a
decrease in DG stem cell proliferation and self-renewal.
Although MAPK pathway can mediate cell proliferation,
it can also be involved in memory performance. Indeed,
depending on the frequency of METH exposure, an acute (Cao
et al., 2013) or chronic (Ito et al., 2007) administration can
improve or decline memory performance, accompanied with
an increase or decrease in the phosphorylation levels of ERK1/
2, respectively. Furthermore, ERK1/2 activation leads to
the activation of the downstream transcription factor cyclic
adenosine monophosphate response element-binding protein
339Methamphetamine impairs dentate gyrus stem cell properties(CREB) followed by increased expression of c-fos, which in
the DG identifies neurons processing spatial information
(Sweatt, 2001). Noteworthy, activation of ERK1/2 is necessary
to generate long-term potentiation in DG immature neurons
(Darcy et al., 2014). Interestingly, Kee et al. (2007) verified
that immature neurons present increased c-fos expression,
which strongly suggest that these cells are recruited to
integrate spatial memory circuitries. Accordingly, in the
present study we demonstrate that METH transiently
decreased pERK1/2 protein levels in DG stem cells and
increased immature neurons, which allow us to hypothesize
that these neurons can be synaptically active and thereby
participate in memory processes.
Other important characteristic of neural stem cells is the
ability to self-renew. Thus, we further explored for the first
time the effect of METH on DG stem cell self-renewal. METH,
at nontoxic concentrations (1 nM or 10 nM), was able to
decrease the number of primary neurospheres, showing
that this drug has a negative effect on stem cell prolifer-
ation. In fact, the findings obtained in cell cycle analysis
can be correlated with the decreased number of primary
neurospheres. Specifically, METH delayed G0/G1-to-S phase
progression which decreased the proliferative capacity of DG
stem cells and, consequently, could decrease the number of
neurospheres. Also, at the highest nontoxic concentration
(10 nM), METH decreased the number of secondary
neurospheres proving that it affects DG stem cell self-
renewal. Some studies addressed the effect of METH on DG
neurogenesis and focusedmainly on cell proliferation. In detail,
it has been described that METH (25 mg/kg) transiently
decreases the number of BrdU-positive cells in gerbil dentate
gyrus (Teuchert-Noodt et al., 2000). Moreover, Mandyam et al.
(2008) observed that this drug (0.05 mg/kg/infusion) adminis-
tered 1 h/day and 6 h/day decreases the number of prolifer-
ating cells, characterized by the decreased number of Ki-67-
positive cells, a protein expressed during the active phases
of the cell cycle. Also, METH induces long-term effects in
SGZ stem/progenitor cell proliferation, as described by
Schaefers et al. (2009) showing that a single METH adminis-
tration (50 mg/kg) to 14-day-old gerbils decreases the number
of BrdU-positive cells, 45 days post-administration. In addi-
tion, our group demonstrated that 100 μM METH (48 h of
exposure) reduced proliferation in SVZ cultures (Bento et al.,
2011).
As METH impairs self-renewal capacity, we also explored the
influence of METH in DG stem cell-fate division, a suitable
method to characterize the phenotype of cells that are derived
from the division of one DG stem cell. Indeed, a stem cell can
undergo symmetric cell division towards self-renewal, where
the two resulting cells are both stem cells (Sox2+/Sox2+ pairs of
daughter cells), and towards differentiation, resulting to two
cells that are committed to differentiate (Sox2−/Sox2− pairs of
daughter cells). Moreover, one stem cell can divide asymmet-
rically, originating to one pair of cells consisting of one Sox2+
and one Sox2− cell. Accordingly, we found that METH (10 nM)
decreased self-renewal symmetric cell division (Sox2+/Sox2+
pairs of daughter cells), directing division towards Sox2−/Sox2−
pairs of daughter cells consistent with cell commitment. In fact,
an animal study showed that Sox2-positive cells in the SGZ are
able to undergo symmetric or asymmetric cell division, in
which one Sox2-positive cell can give rise to one neuron and
one astrocyte, or to one neural stem cell and one neuron,respectively (Suh et al., 2007). Also, we observed that these
alterations could be, in part, due to the activation of NMDA
receptor signaling because inhibition of these receptors
prevented the shift of cell division towards differentiation.
Moreover, we had previously demonstrated that METH induces
an increase of glutamate release fromDG neurospheres and the
inhibition of NMDA receptors protects DG cells from METH
toxicity (Baptista et al., 2012). In fact, several brain injuries,
such as status epilepticus (Sugaya et al., 2010), cerebral
ischemia (Choi et al., 2012) and traumatic brain injury (Zheng
et al., 2013) can increase neurogenesis, and glutamate seems
to play a central role upon activation of NMDA receptors
(Arvidsson et al., 2001; Urbach et al., 2008). Indeed, Nacher
et al. (2003) observed that a single injection of NMDA receptor
antagonist (CGP-43487, 5 mg/kg) prevents age-induced de-
crease of SGZ cell proliferation and neurogenesis in both
middle-aged (10 month-old) and aged (20 month-old) Fisher
F344 rats. Moreover, administration of NMDA (30 mg/kg) to
Sprague–Dawley rats decreased the population of proliferating
cells in the DG, whereas administration of MK-801 or CGP37849
resulted in the opposite effect (Cameron et al., 1995). Also,
MK-801 administration (3 mg/kg) to NMDA-infused (2 mg/ml)
Wistar rats increases the phosphorylated levels of ERK in newly
generated neurons (Okuyama et al., 2004), which strengths the
involvement of NMDA receptors in decreasing cell proliferation
through regulation of the MAPK pathway. Moreover, Deisseroth
et al. (2004) demonstrated that NMDA receptors play an active
role in neuronal differentiation, showing that excitatory stimuli
induced by NMDA receptor activation enhances expression of
NeuroD, a downstream regulator of neuronal differentiation,
and consequently increases neurogenesis in neural progenitor
cells culture.
The present study also reveals that METH (10 nM) enhanced
differentiation into immature neurons in DG neurospheres,
verified by the increase of DCX protein levels. This effect
correlates with the fact that METH increases the pairs of
cells that did not express Sox2 (Sox2−/Sox2− cell pairs),
i.e., differentiating cells. Furthermore, cell cycle alter-
ations induced by METH suggest a differentiation shift. In
fact, the length of G1 phase may influence the decision for a
neural stem cell to proliferate or differentiate as reviewed
by Salomoni and Calegari (2010). Furthermore, METH did
not induce any alterations in GFAP expression, indicating
that immature neurons are preferentially generated rather
than astrocytes. In accordance with our findings, it was
described by Mandyam et al. (2008) that METH self-
administration (0.05 mg/kg/infusion, 1 h/day, 2 days/week
for 49 days) increases neuronal differentiation andmaturation
of hippocampal progenitor cells.Conclusions
Our results show that METH interferes with DG stem
cell proliferation, an effect due to a delay on cell
cycle G0/G1-to-S transition involving down-regulation
of pEGFR, cyclin E and pERK1/2. Additionally, METH
impairs DG cell self-renewal capacity via NMDA signal-
ing. These effects could be useful to elucidate the
impairment of hippocampal neurogenesis and memory
deficits in METH abusers.
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